• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 13 of 100
Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
Finance
Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
By Sara Sjolin, Sanne Wass, Oliver Crook and BloombergSeptember 23, 2024
COVID-19 symptoms can be mild, severe, or nonexistent, according to the Centers for Disease Control and Prevention—and can appear as late as two weeks after you’ve been exposed to the virus.
Health
Could it be COVID? Here are the symptoms to watch out for in 2024
By Lindsey LeakeSeptember 21, 2024
Mark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could
Leadership
Mark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could
By Sydney LakeSeptember 16, 2024
Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’
Newsletters
Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’
By Sheryl EstradaSeptember 10, 2024
Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it
Commentary
Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it
By Alex ZhavoronkovSeptember 9, 2024
The Fortune 500 is built on more than money. It’s built on human, social, and natural capital, too
Leadership
The Fortune 500 is built on more than money. It’s built on human, social, and natural capital, too
By Andre Hoffmann and Peter VanhamSeptember 6, 2024
Half of Denmark’s GDP growth in 2024 will be thanks to Novo Nordisk, analysts predict
Tech
Half of Denmark’s GDP growth in 2024 will be thanks to Novo Nordisk, analysts predict
By Sanne Wass and BloombergSeptember 3, 2024
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
Health
New COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
By Lindsey LeakeAugust 29, 2024
Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma
Commentary
Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma
By Andrei Iancu and David J. KapposAugust 28, 2024
Novo Nordisk’s weight-loss drugs and Bavarian Nordic’s mpox vaccine help fatten up the Danish economy
Finance
Novo Nordisk’s weight-loss drugs and Bavarian Nordic’s mpox vaccine help fatten up the Danish economy
By Sanne Wass and BloombergAugust 20, 2024
The three founders of Photon Health sitting on a brown sofa and posing for a photo.
Tech
This startup believes shopping around for prescription drugs should be as easy as shopping on Amazon. The future of a $700 billion industry is at stake
By Jason Del ReyAugust 15, 2024
MeAgainMeds.com, a free tool developed by researchers at the George Mason University College of Public Health in Fairfax, Va., uses AI to pair people with depression with the best available antidepressant medication for them.
Mind
Antidepressant not working? AI may do a better job than your doctor in matching you with the best medicine
By Lindsey LeakeAugust 14, 2024
Exclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
Health
Exclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
By Alexa MikhailAugust 14, 2024
Here’s the real reason Ozempic-like weight-loss drugs are so popular
Commentary
Here’s the real reason Ozempic-like weight-loss drugs are so popular
By Bill NovelliAugust 12, 2024
FDA sign
Health
FDA rejects psychedelic drug MDMA as a treatment for PTSD
By Matthew Perrone and The Associated PressAugust 10, 2024
1...
  • 11
  • 12
  • 13
  • 14
  • 15
...100
Most Popular
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
North America
Pentagon orders bases to plan for 90 days without the grid as Britain urges families to stockpile food and waterplaceholder alt text
By Bilin LinOctober 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.